Periodoncia.Eley.6a.Ed

376 Periodoncia
Bartholmeusz A, Locarnini S: Mutations in the hepatitis B virus polymerase that are
associated with resistance to famciclovir and lamivudine, International Antiviral News
5:123–124, 1997.
Dahlén G, Wikström M: Occurrence of enteric rods, staphylococci and Candida in
subgingival samples, Oral Microbiol Immunol 10:42–46, 1995.
Denning DW, Baily GG, Hood SV: Azole resistance in Candida, Eur J Clin Microbiol
Infect Dis 16:261–280, 1997.
Dienstay JL, Perillo RP, Schiff ER, et al: A preliminary trial of lamivudine for chronic
hepatitis B infection, Lancet 333:1657–1661, 1995.
Drew W, Bubbles W: Antiviral drug resistance. In Richman D, editor: Drug Resistance,
London, 1997, Wiley.
Egusa H, Nikawa H, Makihira S, et al: Intercellular adhesion molecule 1-dependent
activation of interleukin 8 expression in Candida albicans-infected human gingival
epithelial cells, Infect Immun 73:622–626, 2005.
González S, Lobos I, Guajardo A, et al: Yeasts in juvenile periodontitis, J Periodontol
58:119–124, 1987.
Green RJ, Harris ND: Infections and antimicrobial therapy. In Pathology and
Therapeutics for Pharmacists .A Basis for Clinical Pharmacy Practice, Ch. 12.
London, 1993, Chapman, Hall, pp. 548–558.
Guimarães AL, Correia-Silva J, de F, Sá AR, et al: Investigation of functional gene
polymorphisms IL-1a, IL-6, IL-10 and TNF-a in individuals with recurrent aphthous
stomatitis, Arch Oral Biol 52:268–272, 2007.
Hitchcock CA, Pye GW, Troke PF, et al: Fluconazole resistance in Candida glabrata,
Antimicrob Agents Chemother 37:1962–1965, 1993.
Japour A, Welles S, D’Aquila R: Mutations in human immunodeficiency virus isolated
from patients following long-term zidovudine treatment, J Infect Dis 171:1172–1179,
1995.
Järvensivu A, Heitanen J, Rautemaa R, et al: Candida yeasts in adult periodontitis tissues
and subgingival microbial biofilms in vivo, Oral Dis 10:106–112, 2004.
Johnson EM, Davey KG, Szekely A, et al: Itraconazole susceptibilities of fluconazole
susceptible and resistant isolates of five Candida species, J Antimicrob Chemother
36:787–793, 1995.
Kellam P, Boucher CA, Larder BA: Fifth mutation in human immunodeficiency virus
type 1 reverse transcriptase contributes to the development of high-level resistance to
zidovudine, Proc Natl Acad Sci USA 89:1934–1938, 1992.
Koray M, Ak G, Kurklu E, et al: Fluconazole and/or hexetidine for management of
oral candidiasis associated with denture-induced stomatitis, Oral Dis 11:309–313,
2005.
Larder BA, Kemp SD, Harrigan PR: Potential mechanism for sustained antiretroviral
efficacy of AZT-3TC combination therapy, Science 269:696–699, 1995.
Law D, Moore C, Joseph L: High incidence of antifungal drug resistance in Candida
tropicalis, Int J Antimicrob Agents 7:241–245, 1996.
Main L, Bown JL, Howells C, et al: A double blind, placebo controlled study to assess
the effect of famciclovir on virus replication in patients with chronic hepatitis B virus
infection, J Viral Hepat 3:211–215, 1996.
Manfredi M, McCullough MJ, Polonelli L, et al: In vitro antifungal susceptibility to six
antifungal agents of 229 Candida isolates from patients with diabetes mellitus, Oral
Microbiol Immunol 21:177–182, 2006.
Neu HC: Antimicrobial chemotherapy. In Baron S, Jennings PM, editors: Medical
Microbiology, ed 3, New York, 1991, Churchill Livingstone, Ch. 11, pp 179–201, .
Odds FC: Candida and Candidosis, London, 1988, Baillière Tindall.
Pemberton MN, Oliver RJ, Theaker ED: Miconazole oral gel and drug interaction, Br
Dent J 196:529–531, 2004.
Pottage JC Jr, Kessler HA: : Herpes simplex virus resistance to acyclovir: clinical
relevance, Infect Agents Dis 4:115–124, 1995.
Price MF, LaRocco MT, Gentry LO: Fluconazole susceptibilities of Candida species and
distribution of species recovered from blood cultures over a 5-year period, Antimicrob
Agents Chemother 38:1422–1427, 1994.
Rams TE, Flynn MJ, Slots J: Subgingival microbial associations in severe human
periodontitis, Clin Infect Dis 25:S224–S226, 1997.
Reyes M, Grabber JM, Weatherall N, et al: Acyclovir-resistant herpes simplex virus;
preliminary results from a national surveillance system, Antiviral Res 37:44, 1998.
Reynaud AH, Nygaard-Østby B, Bøygard G-K, et al: Yeasts in periodontal pockets, J Clin
Periodontol 28:860–864, 2001.
Safrin S, Berger TG, Gilson I: Foscarnet therapy in five patients with AIDS and
acyclovir-resistant varicella zoster infection, Ann Intern Med 115:19–21, 1991 a.
Safrin S, Crumpacker C, Chatis P, et al: A controlled trial comparing foscarnet with
vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired
immunodeficiency syndrome. The AIDS Clinical Trials Group, N Engl J Med 325:551–
555, 1991 b.
Schulten EA, ten Kate RW, van der Waal I: Oral manifestations of HIV infection in 75
Dutch patients, J Oral Pathol Med 18:42–46, 1989.
Scully C, Felix DH: Oral medicine-update for the dental practitioner. Aphthous and other
common ulcers, Br Dent J 199:259–264, 2005 a.
Scully C, Felix DH: Oral medicine -update for the dental practitioner. Mouth ulcers of
more serious connotation, Br Dent J 199:339–343, 2005 b.
Shafer WG, Hine MK, Levy BM: A Textbook of Oral Pathology, ed 4, Philadelphia, 1983,
Saunders.
Slavin MA, Bindra RR, Gleaves CA, et al: Ganciclovir sensitivity of cytomegalovirus at
diagnosis and during treatment of cytomegalovirus pneumonia in marrow transplant
recipients, Antimicrob Agents Chemother 37:1360–1363, 1993.
Slots J, Rams TE, Listgarten MA: Yeasts, enteric rods and pseudomonads in the
subgingival flora of severe adult periodontitis, Oral Microbiol Immunol 3:47–52, 1988.
Standing Medical Advisory Committee, Subgroup on Antimicrobial Resistance Current
resistance problems in the UK and worldwide. In DoH, The Path of Least Resistance ,
Ch. 10, London, 1999, Department of Health, 33-54.
Vanden Bossche H, Warnock DW, Dupont B, et al: Mechanisms and clinical impact of
antifungal drug resistance, J Med Vet Mycol 32:S189–S202, 1994.
Voss A, Kluytmans JA, Koeleman JG, et al: Occurrence of yeast bloodstream infections
between 1987 and 1995 in five Dutch university hospitals, Eur J Clin Microbiol Infect
Dis 15:909–912, 1996.
White DJ, Johnson EM, Warnock DW: Management of persistent vulvo vaginal
candidosis due to azole-resistant Candida glabrata, Genitourin Med 69:112–114, 1993.
Wingard JR, Merz WG, Rinaldi MG, et al: Increase in Candida krusei infection among
patients with bone marrow transplantation and neutropenia treated prophylactically
with fluconazole, N Engl J Med 325:1274–1277, 1991.